Olli-P Kallioniemi
Affiliations: | The George Washington University, Washington, DC, United States |
Area:
Genetics, Molecular BiologyGoogle:
"Olli-P Kallioniemi"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ammad-ud-din M, Georgii E, Gönen M, et al. (2014) Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization. Journal of Chemical Information and Modeling. 54: 2347-2359 |
| Hudson TJ, Anderson W, et al. (2010) International network of cancer genome projects. Nature. 464: 993-8 |
| Autio R, Kilpinen S, Saarela M, et al. (2009) Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations Bmc Bioinformatics. 10: 1-12 |
| Lugli A, Spichtin H, Maurer R, et al. (2005) EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6450-8 |
| Rökman A, Baffoe-Bonnie AB, Gillanders E, et al. (2005) Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Human Genetics. 116: 43-50 |
| Syrjäkoski K, Kuukasjärvi T, Waltering K, et al. (2004) BRCA2 mutations in 154 finnish male breast cancer patients. Neoplasia (New York, N.Y.). 6: 541-5 |
| Järvinen AK, Hautaniemi S, Edgren H, et al. (2004) Are data from different gene expression microarray platforms comparable? Genomics. 83: 1164-8 |
| Wolf M, Mousses S, Hautaniemi S, et al. (2004) High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia (New York, N.Y.). 6: 240-7 |
| Srivastava M, Bubendorf L, Raffeld M, et al. (2004) Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2344-50 |
| Syrjäkoski K, Kuukasjärvi T, Auvinen A, et al. (2004) CHEK2 1100delC is not a risk factor for male breast cancer population. International Journal of Cancer. 108: 475-6 |